The NYSE Welcomes vVARDIS as a Publicly Listed Company
View all comments(0)
NEW YORK, Nov. 14, 2026 /PRNewswire/ -- vVARDIS (NYSE: VVVV) co-founders Dr. Haley Abivardi and Dr. Goly Abivardi aim to reshape the future of dental care with a drill-free treatment for the world's #1 non-communicable disease: cavities.
The NYSE welcomes vVARDIS as a publicly listed company! vVARDIS co-founders Dr. Haley Abivardi and Dr. Goly Abivardi aim to reshape the future of dental care with a drill-free treatment for the world’s #1 non-communicable disease: cavities.
- vVARDIS Solves a Problem that Millions Face
- Tooth decay affects billions of people worldwide, and dental anxiety keeps millions from getting the care they need.
- vVARDIS is a Swiss dental technology company focused on changing the way early tooth decay is treated.
- vVARDIS has introduced a new approach that aims to treat decay earlier and more comfortably for patients.
- Its flagship product, Curodont® Repair Fluoride Plus, uses proprietary peptide technology to help repair early-stage tooth decay by supporting the natural remineralization of enamel --- simply put No drill, No needle, or No filling.
- Tooth Decay is One of the Most Common Health Issues in the World
- 2.5 billion people globally live with untreated tooth decay.
- Nearly 90% of U.S. adults have experienced tooth decay.
- Nearly 73% of U.S. adults report dental fear.
- 21% avoid the dentist because of anxiety.
- The Story that Helped Shape vVARDIS
- For decades, treating early tooth decay often meant waiting until it worsened or getting a filling.
- The founders spent 25 years developing Curodont® Repair Fluoride Plus, a treatment that helps repair early tooth decay before it becomes a cavity.
- Curodont® gives dentists a way to treat early decay while making the experience easier and less intimidating for patients.
- The technology has already treated more than 2.5 million teeth
- Available in more than 20% of U.S. dental practices
Click Here to Learn More about vVARDIS: https://www.youtube.com/watch?v=T1p9hUR5Glk
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Like
Recommended Articles
Featured Tools
Top News
Nvidia Q3 Revenue Surges 103%, Next-Quarter Revenue Guidance Reaches $130 Billion, Shares Briefly Rise Over 4% After Hours

【US Pre-Market】Nvidia Rises Nearly 1% Ahead of Post-Market Earnings as US Tightens AI Chip Remote Access Restrictions

Micron Plunges 8% in a Day Near Six-Month Low: Can $700 Support Hold?

US October Retail Sales Preview: Will US Consumer Spending Cool? Fed December Rate Hike Expectations Face Another Test

Nvidia Q3 Earnings Loom as Market Expects Revenue Near $109 Billion: Can NVDA Stock Hold $150?









Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.